Mia Levy, MD, PhD
@drmialevy
Breast medical oncologist, biomedical informatics researcher, founder of MyCancerGenome, Chief Medical Officer Foundation Medicine, Inc. Views are my own.
ID: 1103726214362132480
07-03-2019 18:36:50
256 Tweet
785 Takipçi
403 Takip Edilen
We're excited to share this announcement on our partnership with Roche France & Gustave Roussy to provide in-house liquid biopsy testing for cancer patients in France. Read the full press release here: bit.ly/3EKvrbu
WATCH: Matthew A. Powell, MD, discusses the recommended biomarker testing for patients with endometrial cancer and the frontline options available in dMMR/MSI-H endometrial cancer. #gyncsm | Test Account targetedonc.com/view/recommend…
Great new blog from our Chief Commercial Officer Annie Murphy exploring the coverage landscape for comprehensive genomic profiling, and how Foundation Medicine is working to improve patient access to these tests.
Great conversation with Deanna van Gestel about increasing opportunities for women in oncology.
I’m proud to be part of Foundation Medicine as we adopt new clinical technology that benefits patients. We're introducing the next generation of liquid biopsy through our unique clinical measure that can deliver more definitive, clinically actionable results. bit.ly/3sVXpyz